Adrenergic alpha-Agonists
Research News and Information

Sunday, November 22, 2009

Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: a randomized controlled trial (DEXmedetomidine COmpared to Morphine-DEXCOM Study).

30 Oct 2009 BACKGROUND: Commonly used sedatives/analgesics can increase the risk of postoperative complications, including delirium. This double-blinded study assessed the neurobehavioral, hemodynamic, and sedative characteristics of dexmedetomidine compared ... Read more...

Perineural dexmedetomidine added to ropivacaine causes a dose-dependent increase in the duration of thermal antinociception in sciatic nerve block in rat.

30 Oct 2009 BACKGROUND: The current study was designed to test the hypothesis that dexmedetomidine added to ropivacaine would increase the duration of antinociception to a thermal stimulus in a dose-dependent fashion in a rat model of sciatic nerve blockade. ... Read more...

When drugs disappear from the patient: elimination of intravenous medication by hemodiafiltration.

30 Oct 2009 Twenty-three hours after heart transplantation, life-threatening acute right heart failure was diagnosed in a patient requiring continuous venovenous hemodiafiltration (CVVHDF). Increasing doses of catecholamines, sedatives, and muscle relaxants ... Read more...

Latest indexed articles for 'Adrenergic alpha-Agonists'

These are the very latest articles for this heading:

• Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: a randomized controlled trial (DEXmedetomidine COmpared to Morphine-DEXCOM Study). 30 Oct 2009
• Perineural dexmedetomidine added to ropivacaine causes a dose-dependent increase in the duration of thermal antinociception in sciatic nerve block in rat. 30 Oct 2009
• When drugs disappear from the patient: elimination of intravenous medication by hemodiafiltration. 30 Oct 2009
• Protein kinase C mediates the synergistic interaction between agonists acting at alpha2-adrenergic and delta-opioid receptors in spinal cord. 19 Oct 2009
• The possible mechanism of clonidine to suppress fentanyl-induced coughing. 29 Sep 2009
• Effectiveness of daily use of brimonidine as antimydriatic agent. 29 Sep 2009
• Re: Addition of clonidine or dexmedetomidine to bupivacaine prolongs caudal analgesia in children. 29 Sep 2009
• New caudal additives in children: benefit vs. risk? 30 Aug 2009
• Toxicity from a clonidine suspension. 30 Aug 2009
• Standardization of some electrocardiographic parameters of captive leopard cats (Leopardus tigrinus). 30 Aug 2009
• Pulse contour analysis aids the understanding of autonomic dysreflexia: hemodynamic findings in a T5 paraplegic surgical patient treated for hypotension with phenylephrine and ephedrine. 20 Aug 2009
• Alpha2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients. 16 Aug 2009
• Aerobic exercise and intraocular pressure in normotensive and glaucoma patients. 11 Aug 2009
• [Cardiac arrest induced by dexmedetomidine] 30 Jul 2009
• [Effect of dexmedetomidine on intraoperative somatosensory evoked potential monitoring] 30 Jul 2009
• Clonidine in perioperative medicine and intensive care unit: more than an anti-hypertensive drug. 30 Jul 2009
• Dexmedetomidine use in general anaesthesia. 30 Jul 2009
• Increased risk for flap dislocation with perioperative brimonidine use in femtosecond laser in situ keratomileusis. 30 Jul 2009
• Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome. 30 Jul 2009
• Effect of administration of propofol and xylazine hydrochloride on recovery of horses after four hours of anesthesia with desflurane. 30 Jul 2009

See a longer list of these articles.

Technical information about 'Adrenergic alpha-Agonists'

Definition: Drugs that selectively bind to and activate alpha adrenergic receptors.

Registry Number: 0

Descriptor UI: D000316

Alternative terms: Adrenergic alpha-Agonists; Adrenergic alpha Agonists; alpha-Agonists, Adrenergic; Receptor Agonists, Adrenergic alpha; Receptor Agonists, alpha-Adrenergic; Agonists, alpha-Adrenergic Receptor; Receptor Agonists, alpha Adrenergic; alpha-Adrenergic Receptor Agonist; Agonist, alpha-Adrenergic Receptor; Receptor Agonist, alpha-Adrenergic; alpha Adrenergic Receptor Agonist; alpha-Adrenergic Receptor Agonists; alpha Adrenergic Receptor Agonists; Adrenergic alpha-Agonist; Adrenergic alpha Agonist; alpha-Agonist, Adrenergic; alpha-Adrenergic Agonist; Agonist, alpha-Adrenergic; alpha Adrenergic Agonist; alpha-Adrenergic Agonists; Agonists, alpha-Adrenergic; alpha Adrenergic Agonists; Adrenergic alpha-Receptor Agonist; Adrenergic alpha Receptor Agonist; Agonist, Adrenergic alpha-Receptor; alpha-Receptor Agonist, Adrenergic; Adrenergic alpha-Receptor Agonists; Adrenergic alpha Receptor Agonists; Agonists, Adrenergic alpha-Receptor; alpha-Receptor Agonists, Adrenergic;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications;

Tree Number: D27.505.519.625.050.100.100; D27.505.696.577.050.100.100;

Online Note: use ADRENERGIC ALPHA-AGONISTS to search ADRENERGIC ALPHA RECEPTOR AGONISTS 1969-94 (as Prov 1969-72)

History Note: 95; was ADRENERGIC ALPHA RECEPTOR AGONISTS 1969-94 (Prov 1969-72)

Technical Notes: GEN or unspecified; prefer specifics; do not confuse with ADRENERGIC ALPHA-ANTAGONISTS; DF: ADREN ALPHA AGON or ADREN ALPHA AG